Stay updated on PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Sign up to get notified when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.

Latest updates to the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page
- CheckyesterdayChange DetectedRevision label on the study page changed from v3.5.3 to v3.5.4, signaling a minor update to the ClinicalTrials.gov record. No substantive study content, such as eligibility criteria or results, appears to be affected by this change.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision/version indicator was updated from “v3.5.2” to “v3.5.3,” reflecting a minor site release without changing the displayed study details.SummaryDifference0.1%

- Check29 days agoChange DetectedPage revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.5.0 added. Revision: v3.4.3 removed.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision updated to v3.4.2. Previous notices, including the government funding lapse notice and Revision: v3.4.1, were removed.SummaryDifference0.5%

Stay in the know with updates to PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Enter your email address, and we'll notify you when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.